Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. - Wikidata - awgldk - TriplyDB

Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

http://www.wikidata.org/entity/Q33398833

about

Vaccines for preventing influenza in healthy adults Vaccination of healthcare workers: A review A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System.Vaccine administration and the development of immune thrombocytopenic purpura in children Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.Seasonal Association of Immune Thrombocytopenia in Adults.Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients.How we manage immune thrombocytopenia in the elderly.Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.Torsade de pointes tachycardia in a patient on dronedarone therapy.Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases.Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day.A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion.

P2860

Q24197955-BB7A9F35-5C07-4438-9D09-692B5DAB361D Q26796300-5B7BA5FA-A81D-41CF-9458-79544CDEA2CF Q27686838-D600F74A-2CE5-47E7-8970-D739B2280FF3 Q28535471-5246094F-2648-4D44-B10E-F4499D2002F2 Q31133235-6D1AA8D1-9BEF-43BE-80EE-377C2668EC3A Q33405328-685062FE-8111-4661-BA2F-26C7577BC02D Q33406171-A89320BC-7C41-401B-A6C6-797675E68EAA Q33418883-58050214-C884-4328-BBB4-4FC8ADDF474F Q33425721-362A83FB-614A-4AB7-BEE2-E01166EE812B Q33428973-33C9CE0C-E9CC-4ADC-BB3C-15F8731694AD Q33430899-8CD8EA8B-D50D-49DA-925B-22C54D592FC0 Q33431371-EA2C84D5-3386-49A1-80F3-C09E6FF71A81 Q33442116-D034262B-E38B-4D51-9818-DFC959AFDEE7 Q34446727-BFF856A4-F289-4ED8-8775-5CCB094E58E5 Q35684831-1FD477E5-2050-4E2A-AB34-7DC95380700E Q46455559-72D5303A-8223-431B-888A-004DD8E74649 Q50028367-DBC670E9-396E-4789-BB38-AAB69D382BB8 Q52868276-4FACF615-2D08-46DC-9A36-AEB9CC224E45 Q52882777-C0C7D42F-DC95-4E23-9053-5EF655D6BAE5 Q53791853-C082AE01-29B5-4E9E-AE80-85AD1BE1A5CD Q55442994-01909C21-AD12-4F25-A016-498699EBAD97

P2860

Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

http://www.wikidata.org/entity/Q33398833

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@ast

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@en

type

label

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@ast

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@en

prefLabel

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@ast

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@en

P1433

Q33398833-B36923DA-BBAD-463C-A5E9-6E993C89D5A9

P1476

Q33398833-BDC1948C-8D61-4BD4-A8E0-69F26C04032D

P2093

Q33398833-091DE64F-2AAB-4FAA-B74B-8823824F91BD

Q33398833-0BEDE91C-6009-47FA-B4E7-BDFF4028E567

Q33398833-297B1081-C029-40D8-A283-98A646DF0A03

Q33398833-4A0B1905-89F8-4090-9194-A4AE3AE8BA5C

Q33398833-7E64C43E-4502-4831-BE86-5A0B35688D33

Q33398833-80280813-D0AC-4D01-8F1C-3A6D28BF185C

Q33398833-A4ABD214-D453-4828-B898-A94FFC314784

Q33398833-AE351F2C-4CA8-40AD-B3AF-5041DA653B05

Q33398833-B3984D94-5684-43E6-A028-B57E0E0E83F2

Q33398833-D122DE53-EFC2-4789-839B-EB9006F94001

P2860

Q33398833-0869D654-4AAE-4B3F-92E4-40CEDBD889D7

Q33398833-0B02CFA3-A60E-4BD6-A6B4-64114FD3C0CA

Q33398833-265EA3B6-B141-4063-8FC9-9FAAF2D456F6

Q33398833-27409562-C17D-422D-B95D-6F519404D057

Q33398833-2BD787F5-0C89-4F27-AD36-69CCA01E939F

Q33398833-3221F730-AFDF-4D1D-A21A-6F420738D978

Q33398833-3642BD00-5A70-4B44-B997-11A215DBBF13

Q33398833-3E0E5318-CB31-49C3-8899-0D266B3BF3F2

Q33398833-40034C7F-5E6D-4C2D-A1A9-670F8A74F3EF

Q33398833-42EE2E94-9312-456F-B469-43912657948E

P2888

Q33398833-F90137AD-5E68-4846-95A7-845A856F3693

P304

Q33398833-0F377A4C-3583-41CA-8551-B87639ED08B7

P31

Q33398833-50865AC7-101C-4FDC-9915-952CBFB4321F

P356

Q33398833-6DA197B2-8705-4A6E-BCDA-647A4A1AA29A

P433

Q33398833-7BEC0173-BFEF-480D-8EA6-FD24DE77BA3D

P478

Q33398833-ADF5594B-1834-4CC5-BF58-0EE7E7279FD1

P577

Q33398833-DDAA6891-505B-4BFF-AE32-057DE8C500D7

P6179

Q33398833-AD6209E3-8E02-4F97-8D31-A2E8E518437D

P698

Q33398833-39A975A6-F5EA-44B7-BDF8-FD2499C9F8BC

P921

Q33398833-D3251154-3B87-4D8F-9DDA-4D6CE67DFFDB

P356

S00228-011-1184-3

P1433

European Journal of Clinical Pharmacology

P1476

Drug-induced immune thrombocyt ...... se-Control Surveillance Study.

@en

P2093

Abdulgabar Salama

http://www.w3.org/2001/XMLSchema#string

Andreas Grüneisen

http://www.w3.org/2001/XMLSchema#string

Andreas Klimpel

http://www.w3.org/2001/XMLSchema#string

Edeltraut Garbe

http://www.w3.org/2001/XMLSchema#string

Elisabeth Bronder

http://www.w3.org/2001/XMLSchema#string

Ernst Späth-Schwalbe

http://www.w3.org/2001/XMLSchema#string

Frank Andersohn

http://www.w3.org/2001/XMLSchema#string

Hanife Kurtal

http://www.w3.org/2001/XMLSchema#string

Hubert Schrezenmeier

http://www.w3.org/2001/XMLSchema#string

Martin Hildebrandt

http://www.w3.org/2001/XMLSchema#string

P2860

Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment.

Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets.

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug.

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.

Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study.

Drug-induced immune thrombocytopenia.

Eptifibatide-associated acute, profound thrombocytopenia.

Drug-induced thrombocytopenia: a population study.

Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.

P2888

s00228-011-1184-3

P304

821-832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-011-1184-3

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013425217

http://www.w3.org/2001/XMLSchema#string

P698

22187020

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia